FDA Inspection 1153712 — Alcresta Therapeutics, Inc.
The FDA completed an inspection of Alcresta Therapeutics, Inc. on September 13, 2021 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Waltham, MA (United States)